Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2016-08-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2016.06.005PMID 27283486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Permeability-Glycoprotein Inhibition at the Human Blood–Brain Barrier Can Be Safely Achieved by Performing PET During Peak Plasma Concentrations of Tariquidar

  2015cited by this paper
• Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[11C]verapamil PET study

  2015cited by this paper
• Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography

  2015cited by this paper
• Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

  2015cited by this paper
• Influence of P-Glycoprotein Inhibition or Deficiency at the Blood–Brain Barrier on 18F-2-Fluoro-2-Deoxy-d-glucose (18F-FDG) Brain Kinetics

  2015cited by this paper
• Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys

  2014cited by this paper
• Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

  2014cited by this paper
• Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

  2013cited by this paper
• Effects of Selected OATP and/or ABC Transporter Inhibitors on the Brain and Whole-Body Distribution of Glyburide

  2013cited by this paper
• Species differences in drug transporters and implications for translating preclinical findings to humans

  2013cited by this paper
• Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.

  2013cited by this paper
• The P-glycoprotein transport system and cardiovascular drugs.

  2013cited by this paper
• Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence‐Based Position

  2013cited by this paper
• Imaging P-glycoprotein function in rats using [11C]-N-desmethyl-loperamide

  2013cited by this paper
• A high-yield route to synthesize the P-glycoprotein radioligand [11C]N-desmethyl-loperamide and its parent radioligand [11C]loperamide.

  2013cited by this paper
• Modern methods for delivery of drugs across the blood-brain barrier.

  2012cited by this paper
• Discrepancies in the P-glycoprotein-Mediated Transport of 18F-MPPF: A Pharmacokinetic Study in Mice and Non-human Primates

  2012cited by this paper
• P-Glycoprotein Function at the Blood–Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• N-desmethyl-Loperamide Is Selective for P-Glycoprotein among Three ATP-Binding Cassette Transporters at the Blood-Brain Barrier

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Breast Cancer Resistance Protein Interacts with Various Compounds in Vitro, but Plays a Minor Role in Substrate Efflux at the Blood-Brain Barrier

  2009cited by this paper
• Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications

  2009cited by this paper
• Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans

  2009cited by this paper
• Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

  2009cited by this paper
• Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.

  2008cited by this paper
• P-Glycoprotein Function at the Blood–Brain Barrier Imaged Using 11C-N-Desmethyl-Loperamide in Monkeys

  2008cited by this paper
• Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions

  2008cited by this paper
• Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy

  2008cited by this paper
• Dipyridamole enhances digoxin bioavailability via P‐glycoprotein inhibition

  2003cited by this paper
• Clinical pharmacokinetics of dipyridamole.

  1983cited by this paper
• Dipyridamol kinetics.

  1982cited by this paper

• PET-based radiopharmaceuticals for imaging the expression and function of multidrug resistance P-glycoprotein.

  2026cites this paper
• Designing a Small Molecule for PET Radiotracing: [18F]MC225 in Human Trials for Early Diagnosis in CNS Pathologies

  2025influential citation
• New Radiopharmaceutical Tools in Imaging.

  2025cites this paper
• Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer

  2024cites this paper
• EVALUATION OF ABCB1-PROTEIN INHIBITION PROSPECTIVENESS IN HEMATOENCEPHALIC BARRIER AS METHOD FOR INCREASING EFFICIENCY OF PHARMACOTHERAPY IN CEREBRAL ISCHEMIA

  2022cites this paper
• Imaging Technologies for Cerebral Pharmacokinetic Studies: Progress and Perspectives

  2022cites this paper
• A method of inhibiting the ABCB1 protein in the blood-brain barrier in vivo

  2022cites this paper
• Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?

  2021cites this paper
• The Role of P-Glycoprotein at the Blood–Brain Barrier in Neurological and Psychiatric Disease

  2020cites this paper
• Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates

  2020cites this paper
• ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

  2019cites this paper
• Radiosynthesis and evaluation of [11C]CMP, a high affinity GSK3 ligand.

  2019cites this paper
• Imaging techniques to study drug transporter function in vivo.

  2018cites this paper
• Effect and Safety of Morphine Use in Acute Anterior ST‐Segment Elevation Myocardial Infarction

  2018cites this paper
• A mass spectrometry imaging approach for investigating how drug‐drug interactions influence drug blood‐brain barrier permeability

  2018cites this paper
• Physical blood‐brain barrier disruption induced by focused ultrasound does not overcome the transporter‐mediated efflux of erlotinib

  2018cites this paper